Hwail Pharmaceutical Co.,Ltd. (KOSDAQ: A061250)
Health Care · Pharmaceuticals · KR
₩6,500.00
+2.36% today · -44.0% 1Y
Hwail Pharmaceutical Co.,Ltd. (KOSDAQ: A061250) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $40.68M.
Over the last twelve months the share price has lost 44.0%, trading between 6.21K and 12.50K.
Tweenvest scores Hwail Pharmaceutical Co.,Ltd. across four factors: quality 74/100, value 82/100, growth 46/100. Its strongest factor is value.
A061250 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $40.68M
- Revenue (TTM)
- $96.49M
- P/E
- 13.70
- EPS
- 474.50
- Dividend yield
- —
- Beta (5Y)
- 0.17
- 52-week high
- ₩12,500.00
- 52-week low
- ₩6,210.00
- Avg volume (3M)
- —
- Shares outstanding
- 8.41M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Veru Inc.NasdaqCM: VERU | $41.94M | $2.41 | -2.24% |
| Orion Infusion LimitedDSE: ORIONINFU | $41.46M | Tk250.80 | -2.68% |
| Enzymatica AB (publ)OM: ENZY | $41.39M | Skr1.77 | +3.81% |
| Nasus Pharma Ltd.NYSEAM: NSRX | $41.12M | $3.43 | -2.28% |
| SCYNEXIS, Inc.NasdaqCM: SCYX | $40.59M | $4.08 | 0.00% |
| Herantis Pharma OyjHLSE: HRTIS | $39.83M | €1.34 | -5.36% |
| BF Biosciences LimitedKASE: BFBIO | $39.61M | PKRs124.18 | -0.40% |
| Filana Therapeutics, Inc.NasdaqCM: FLNA | $39.46M | $0.77 | -5.94% |
Figures last refreshed Oct 11, 2026.